Danilo Morelli

Dr. Danilo Morelli

Medical Biotechnology, University of Milano-Bicocca, Milan, Lombardy, Italy

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 March 2023 in Cells
Verified
Journal Article
Open access
PDF file
LCLuana Calabrone
Luana Calabrone
VCValentina Carlini
Valentina Carlini
DNDouglas Noonan
Douglas Noonan
MFMarco Festa
Marco Festa
CFCinzia Ferrario
Cinzia Ferrario
Adriana AlbiniAdriana Albini
Adriana Albini
The exploration of natural preventive molecules for nutraceutical and pharmaceutical use has recently increased. In this scenario, marine microorganisms represent an underestimated source of bioactive products endowed with beneficial effects on health that include anti-oxidant, anti-inflammatory, differentiating, anti-tumor, and anti-angiogenic activities. Here, we tested the potential chemopreventive and anti-angiogenic activities of an extract from the marine coastal diatom Skeletonema marinoi Sarno and Zingone (Sm) on prostate cancer (PCa) and endothelial cells. We also tested one of the main carotenoids of the diatom, the xanthophyll pigment fucoxanthin (Fuco). Fuco from the literature is a potential candidate compound involved in chemopreventive activities. Sm extract and Fuco were able to inhibit PCa cell growth and hinder vascular network formation of endothelial cells. The reduced number of cells was partially due to growth inhibition and apoptosis. We studied the molecular targets by qPCR and membrane antibody arrays. Angiogenesis and inflammation molecules were modulated. In particular, Fuco downregulated the expression of Angiopoietin 2, CXCL5, TGFβ, IL6, STAT3, MMP1, TIMP1 and TIMP2 in both prostate and endothelial cells. Our study confirmed microalgae-derived drugs as potentially relevant sources of novel nutraceuticals, providing candidates for potential dietary or dietary supplement intervention in cancer prevention approaches.

3 July 2025 in Cosmetics
Verified
Journal Article
Open access
PDF file
Adriana AlbiniAdriana Albini
Adriana Albini
PCPaola Corradino
Paola Corradino
DMDanilo Morelli
Danilo Morelli
FAFrancesca Albini
Francesca Albini
DNDouglas Noonan
Douglas Noonan
Olive oil and its derivatives, particularly polyphenol-rich extracts, are valued for their antioxidant, anti-inflammatory, and regenerative properties. Olive mill wastewater (OMWW), a byproduct of olive oil production, traditionally seen as an environmental pollutant, has emerged as a promising source of high-value dermatological ingredients. Key polyphenols such as hydroxytyrosol, oleuropein, and tyrosol exhibit potent antioxidant, anti-inflammatory, antimicrobial, and photoprotective effects. These compounds mitigate oxidative stress, prevent collagen degradation, modulate NF-κB and MAPK signaling, and promote cellular repair and regeneration. Skin health is increasingly recognized as crucial to overall well-being, driving interest in cosmeceuticals that combine cosmetic benefits with dermatological activity. This review examines the cosmeceutical and dermatological potential of OMWW, highlighting its incorporation into innovative topical formulations like oil-in-water nanoemulsions, liposomes, and microneedles that enhance skin penetration and bioavailability. Additionally, OMWW fractions have shown selective antiproliferative effects on melanoma cells, suggesting potential for skin cancer prevention. Valorization of OMWW through biorefinery processes aligns with circular-economy principles, converting agro-industrial waste into sustainable cosmeceutical ingredients. This approach not only meets consumer demand for natural, effective products, but also reduces the ecological footprint of olive oil production, offering a scalable, eco-friendly strategy for next-generation dermatological applications.

15 May 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
Adriana AlbiniAdriana Albini
Adriana Albini
PCPaola Corradino
Paola Corradino
DMDanilo Morelli
Danilo Morelli
FAFrancesca Albini
Francesca Albini
DNDouglas Noonan
Douglas Noonan
Skin health is increasingly recognized as crucial to overall well-being, driving interest in cosmeceuticals that combine cosmetic benefits with dermatological activity. Olive oil and its derivatives, particularly polyphenol-rich extracts, are valued for their antioxidant, anti-inflammatory, and regenerative properties. Olive mill wastewater (OMWW), a byproduct of olive oil production, traditionally seen as an environmental pollutant, has emerged as a promising source of high-value dermatological ingredients. Key polyphenols such as hydroxytyrosol, oleuropein, and tyrosol exhibit potent antioxidant, anti-inflammatory, antimicrobial, and photoprotective effects. These compounds mitigate oxidative stress, prevent collagen degradation, modulate NF-κB and MAPK signaling, and promote cellular repair and regeneration. This review examines the dermatological potential of OMWW, highlighting its incorporation into innovative topical formulations like oil-in-water nanoemulsions, liposomes, and microneedles that enhance skin penetration and bioavailability. Additionally, OMWW fractions have shown selective antiproliferative effects on melanoma cells, suggesting potential in skin cancer prevention. Valorization of OMWW through biorefinery processes aligns with circular economy principles, converting agro-industrial waste into sustainable cosmeceutical ingredients. This sustainable approach not only meets consumer demand for natural, effective products but also reduces the ecological footprint of olive oil production, offering a scalable, eco-friendly strategy for next-generation dermatological applications.

4 February 2026 in Antioxidants
Verified
Journal Article
Open access
PDF file
DMDanilo Morelli
Danilo Morelli
LCLuana Calabrone
Luana Calabrone
LPLuisa Di Paola
Luisa Di Paola
GCGiovanna Chiorino
Giovanna Chiorino
POPaola Ostano
Paola Ostano
Adriana AlbiniAdriana Albini
Adriana Albini
Algal carotenoids play a promising role in handling chronic diseases due to their diverse bioactive properties, including anti-inflammatory, antioxidant, and anticancer effects. This study assesses the activity of the antioxidant xanthophyll diatoxanthin (Dt), derived from marine diatoms, against triple-negative breast cancer (TNBC) cells using in vitro models, gene expression evaluation, and explores its role in potentiating the cytotoxic effect of chemotherapy. Dt exhibited selective activity against MDA-MB-231 and BT-549 TNBC cells at concentrations ≥12.5 ng/mL, with maximal effects observed at 25 ng/mL while sparing human umbilical vein endothelial cells (HUVECs) at these doses. When combined with doxorubicin (0.1–0.5 μM), Dt enhanced the anti-tumor efficacy in both TNBC cell lines, further reducing cell viability compared with doxorubicin alone (p < 0.05–0.001). Dt also exerted its activity in inhibiting migration and chemotaxis by approximately 30–50% compared with the controls (p < 0.01) and suppressing 3D-tumor spheroid growth at day 12 (up to >50% reduction, p < 0.001). Notably, secretome analysis revealed Dt-induced changes in inflammatory, oxidative and angiogenic mediators, highlighting its ability to modulate the TNBC microenvironment. Dt also downregulated key pro-survival, pro-angiogenic and pro-tumorigenic genes in both TNBC cell lines, supporting its role in disrupting oncogenic pathways. Angiogenesis-related genes were significantly reduced. Dt also decreased the expression of angiogenic mediators in HUVECs, supporting Dt’s role in inhibiting tumor vascularization. Results on gene expression regulation were also confirmed by RNA-Seq analysis. These findings pose Dt as a promising chemopreventing candidate in the challenging fight against TNBC, a well-known type of cancer that is aggressive and resistant to conventional therapies, targeting critical pathways for tumor survival, such as inflammation, angiogenesis, tumor cell growth, and cell migration. Given its selective activity against TNBC cells, ability to enhance chemotherapy efficacy, and modulation of the tumor microenvironment, Dt holds promise as a complementary drug for cancer prevention and interception. Future studies should focus on validating these effects in vivo and exploring Dt’s potential in combinatorial treatment strategies for cancer.

22 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DMDanilo Morelli
Danilo Morelli
LCLuana Calabrone
Luana Calabrone
LPLuisa Di Paola
Luisa Di Paola
GCGiovanna Chiorino
Giovanna Chiorino
POPaola Ostano
Paola Ostano
Adriana AlbiniAdriana Albini
Adriana Albini
Algal carotenoids play a promising role in handling chronic disease due to their diverse bioactive properties, including anti-inflammatory, antioxidant, and anticancer effects. This study assesses the activity of the antioxidant xanthophyll diatoxanthin (Dt), derived from marine diatoms, against triple-negative breast cancer (TNBC) cells using in vitro models, gene expression evaluation and explorings its role in potentiating the cytotoxic effect of chemotherapy. Dt exhibited selective activity against MDA-MB-231 and BT-549 TNBC cells and when combined with doxorubicin synergistically enhanced anti-tumor efficacy in both TNBC cell lines by further reducing cell viability. Dt also exerted its activity in inhibiting migration, chemotaxis, and suppressing 3D-tumor spheroid growth, and downregulating angiogenesis-related genes. Notably, secretome analysis revealed that Dt-induced changes in inflammatory, oxidative and angiogenic mediators, highlighting its ability to modulate the TNBC microenvironment. Dt also downregulated key pro-survival, proangiogenic and pro-tumorigenic genes in both TNBC cell lines, supporting its role in disrupting oncogenic pathways. Angiogenesis-related genes were significantly reduced. Dt also decreased the expression of angiogenic mediators in HUVEC cells, supporting Dt’s role in inhibiting tumor vascularization. Results on gene expression regulation were confirmed by RNAseq analysis. These findings pose Dt as a multifaceted candidate for contrasting TNBC, capable of targeting inflammation, angiogenesis, tumor cell growhth, and cell migration. Given its selective activity against TNBC cells, ability to enhance chemotherapy efficacy, and modulation of the tumor microenvironment, Dt holds promise as complementary drug for cancer prevention and interception. Future studies should focus on validating these effects in vivo and exploring Dt’s potential in combinatorial treatment strategies for cancer.

7 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
DMDanilo Morelli
Danilo Morelli
SNSara Nofri
Sara Nofri
PCPaola Corradino
Paola Corradino
Domenico E. Pellegrini-GiampietroDomenico E. Pellegrini-Giampietro
Domenico E. Pellegrini-Giampietro
Calogero CarusoCalogero Caruso
Calogero Caruso
Adriana AlbiniAdriana Albini
Adriana Albini
Background: Muscle function determines overall health and is often impaired in metabolic syndrome, largely due to oxidative stress and inflammation. Olive mill wastewater (OMWW) is rich in bioactive polyphenols (e.g., hydroxytyrosol, oleuperine and verbascoside) that may hinder these pro-sarcopenic mechanisms, representing a potential nutraceutical to maintain muscle health. Objective: To evaluate the effects of short-term supplementation with an OMWW-derived polyphenol extract (Oliphenolia®, OMWW-OL) on muscle-related parameters and antioxidant biomarkers in adults at metabolic risk, while maintaining dietary habits. Methods: This exploratory, hypothesis-driven secondary analysis was based on a single-arm longitudinal pilot study assessing patients at baseline (T0), after 30 days of supplementation (T1), and 30 days post-discontinuation (T2). Anthropometry, bioelectrical impedance, and biochemical assessments were performed. Results: Supplementation was associated with modest increases in skeletal muscle mass, muscle mass percentage, and wrist, arm, and calf circumferences. Fat mass decreased progressively, while total body water percentage and hydration status improved. Ferritin levels rose at T2, alongside increases in protein thiols (PSH) and Trolox equivalent antioxidant capacity (TEAC), suggesting improved iron status and reduced oxidative stress. Body weight and BMI decreased, as expected in a dietary intervention for metabolic syndrome, while muscle health showed a tendency to improve. Conclusions: Although findings require cautious interpretation, short-term Oliphenolia® supplementation was associated with modest but consistent directional changes across muscle-related and metabolic indicators in adults at metabolic risk. The results support hypothesis generation and the need for larger studies aimed at investigating the potential preventive role of OMWW-OL in the context of cancer-associated sarcopenia.